pre-ipo
Stage
2015
Founded
1
Investors
About
Tempus uses AI and machine learning to analyze clinical and genomic data to enable precision medicine, providing tailored treatment insights to physicians, hospitals, and pharmaceutical companies.
Explore Tempus's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.